Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis

dc.contributor.author	Burke, Rachael M.
dc.contributor.author	Coronel, Jorge
dc.contributor.author	Moore, David Alexander James
dc.date.accessioned	2019-01-25T17:00:26Z
dc.date.available	2019-01-25T17:00:26Z
dc.date.issued	2017
dc.identifier.uri	https://hdl.handle.net/20.500.12866/4928
dc.description.abstract	We report the range of minimum inhibitory concentrations for six antimicrobial drugs in 228 clinical Mycobacterium tuberculosis (MTB) isolates from three distinct groups of patients (unselected patients, patients at high risk of drug-resistant TB and HIV-positive patients) in Lima, Peru. These data highlight the challenges of and discriminatory characteristics required for MTB drug susceptibility testing.	en_US
dc.language.iso	eng
dc.publisher	Microbiology Society
dc.relation.ispartofseries	Journal of Medical Microbiology
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject	Antitubercular Agents/pharmacology	en_US
dc.subject	Humans	en_US
dc.subject	Microbial Sensitivity Tests	en_US
dc.subject	Mycobacterium tuberculosis/drug effects/isolation & purification	en_US
dc.subject	Peru	en_US
dc.subject	Tuberculosis/microbiology	en_US
dc.title	Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis	en_US
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	https://doi.org/10.1099/jmm.0.000534
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#1.06.01
dc.relation.issn	1473-5644

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.

Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess